Overview
Inger Oynebraten practices practicing medicine in Nydalen, Norway.
Her clinical expertise encompasses Plasmacytoma, Lung Cancer, and Triple-Negative Breast Cancer.
She is actively involved in clinical research, co-authoring 29 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Inger Oynebraten
Is Inger Oynebraten a top-rated expert for Plasmacytoma?
MediFind is an objective health platform that identifies experts based on real-world data. Inger Oynebraten is classified as an Experienced expert for Plasmacytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Inger Oynebraten participate in research or clinical trials?
Yes. Inger Oynebraten has published 29 articles and abstracts on conditions like Plasmacytoma. You can view a list of Inger Oynebraten's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerMs. Oynebraten isExperienced. Learn about Lung Cancer.
- PlasmacytomaMs. Oynebraten isExperienced. Learn about Plasmacytoma.
- Triple-Negative Breast CancerMs. Oynebraten isExperienced. Learn about Triple-Negative Breast Cancer.